Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections

Eitemau Tebyg

• Continuous beta-lactam infusion in critically ill patients: the clinical evidence
  gan: Abdul-Aziz, Mohd H, et al.
  Cyhoeddwyd: (2012)
• Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
  gan: Sime, Fekade Bruck, et al.
  Cyhoeddwyd: (2012)
• Beta-lactam antibiotics in continuous infusion in critically ill patients
  gan: Jeurissen, Axel, et al.
  Cyhoeddwyd: (2010)
• Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?
  gan: Wong, Gloria, et al.
  Cyhoeddwyd: (2013)
• Pharmacokinetics of Piperacillin in Critically Ill Australian Indigenous Patients with Severe Sepsis
  gan: Tsai, Danny, et al.
  Cyhoeddwyd: (2016)